Germany· DE-A57-69a41f14730a67b1

Maexeni 30

A ethinylestradiol, levonorgestrel product containing ethinylestradiol, levonorgestrel, registered in Germany by Hormosan Pharma Gmbh.

ATC Ethinylestradiol, LEVONORGESTREL

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedMaexeni 30ATCEthinylestradiol, LEV…REGISTER NO.DE-A57-69a41f14730a67…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Ethinylestradiol, Levonorgestrel
Manufacturer
Hormosan Pharma Gmbh
Country
Germany (DE)
ATC code
Ethinylestradiol, LEVONORGESTREL
ATC class
Ethinylestradiol, LEVONORGESTREL
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e7bcb2ae-c60d-463d-a569-d0754592b1ad
GET /v1/drugs/e7bcb2ae-c60d-463d-a569-d0754592b1ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Ethinylestradiol, Levonorgestrel",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about ethinylestradiol, levonorgestrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.